Nancy E. Davidson
University of Washington · 830 works · 78,471 citations · h-index 123
Top works
- Mutations in the p53 gene occur in diverse human tumour types
- Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
- Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.
- Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
- Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
- A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer
- Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
- Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
- Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17
- American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
- Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation.
- AACR Project GENIE: Powering Precision Medicine through an International Consortium
- Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal
- Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
- Estrogen Carcinogenesis in Breast Cancer